Fakta om udbudet

EU-nr

2019/S 084-200195

Offentliggjort

30.04.2019

Udbudstype

Opdatering

Udbyder

Amgros I/S

Joint Nordic Procurement of Pharmaceuticals — 2020 — NF 1.621.b

Amgros I/S

Corrigendum

Notice for changes or additional information

Supplies

(Supplement to the Official Journal of the European Union, 2019/S 072-169900)

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority/entity

I.1) Name and addresses

Amgros I/S
Dampfærgevej 22
København Ø
2100
Denmark
Contact person: Flemming Sonne
Telephone: +45 88713000
E-mail: udbud@amgros.dk
Fax: +45 88713008
NUTS code: DK0

Internet address(es):

Main address: http://www.amgros.dk

I.1) Name and addresses

Landspítali
Eiríksgata 5
Reykjavík
101
Iceland
Contact person: Hulda Harðardóttir
E-mail: huldahar@landspitali.is
NUTS code: IS

Internet address(es):

Main address: http://www.rikiskaup.is

I.1) Name and addresses

Sykehusinnkjøp HF, divisjon legemidler
Grev Wedels plass 7
Oslo
0151
Norway
Contact person: Eirik Sverrisson
E-mail: eirik.sverrisson@sykehusinnkjop.no
NUTS code: NO

Internet address(es):

Main address: http://www.sykehusinnkjop.no

Section II: Object

II.1) Scope of the procurement

II.1.1) Title:

Joint Nordic Procurement of Pharmaceuticals — 2020 — NF 1.621.b

II.1.2) Main CPV code

33600000

II.1.3) Type of contract

Supplies

II.1.4) Short description:

Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award Framework Agreements in order to ensure the supply of pharmaceuticals to the public hospitals and health authorities in the countries. In Denmark certain pharmaceuticals is resold to the Faroe Island and Greenland. For this procurement group delivery to Iceland is an option, see section II.2.11.

Tenders for the pharmaceuticals are invited so that the Contracting Authorities can enter into Framework Agreements for delivery of the pharmaceuticals requested in the list of products and specified under the various lots below (section II.2.4).

The Framework Agreements are non-exclusive to the supplier. The hospitals and health authorities are not obliged to use the Framework Agreement.

Section VI: Complementary information

VI.5) Date of dispatch of this notice:

26/04/2019

VI.6) Original notice reference

Notice number in the OJ S: 2019/S 072-169900

Section VII: Changes

VII.1) Information to be changed or added

VII.1.2) Text to be corrected in the original notice

Section number: II.2.4)

Lot No: 1

Place of text to be modified: Description of the procurement:

Instead of:

Volume in units: (Norway: 65500) (Denmark: 1784490) (Iceland: 495).

Read:

Volume in units: (Norway: 65500) (Denmark: 178490) (Iceland: 495).

VII.2) Other additional information:

{{ window.visitor.corporateClient.name }}

Virksomhedsløsning

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}

Fakta om udbudet

Joint Nordic Procurement of Pharmaceuticals — 2020 — NF 1.621.b

Amgros I/S